Mycotopia Therapies Inc (TPIA)
0.04
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Mycotopia Therapies Total Liabilities (Quarterly): 4.599M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.599M |
December 31, 2023 | 4.248M |
September 30, 2023 | 2.055M |
June 30, 2023 | 1.768M |
March 31, 2023 | 1.553M |
December 31, 2022 | 1.279M |
September 30, 2022 | 0.6754M |
June 30, 2022 | 0.5125M |
March 31, 2022 | 0.9586M |
December 31, 2021 | 1.218M |
September 30, 2021 | 0.7162M |
Date | Value |
---|---|
June 30, 2021 | 0.6458M |
March 31, 2021 | 0.1275M |
December 31, 2020 | 0.127M |
September 30, 2020 | 0.0011M |
June 30, 2020 | 0.0108M |
March 31, 2020 | 0.0005M |
December 31, 2019 | 0.5632M |
September 30, 2019 | 0.7664M |
June 30, 2019 | 1.456M |
December 31, 2018 | 0.8529M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0005M
Minimum
Mar 2020
4.599M
Maximum
Mar 2024
1.164M
Average
0.7413M
Median
Total Liabilities (Quarterly) Benchmarks
CEL-SCI Corp | 15.74M |
AIM ImmunoTech Inc | 11.36M |
IGC Pharma Inc | 2.206M |
NovaBay Pharmaceuticals Inc | 5.197M |
Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.145M |
Shareholders Equity (Quarterly) | -2.454M |